Nuo Therapeutics Company
%20.jpg)
Nuo Therapeutics is a biotechnology company that develops, sells, and licenses regenerative biological therapies to primarily address the areas of wound care, inflammation, and angiogenesis. The Company markets the AutoloGel System, a device for the production of platelet rich plasma gel derived from the patient's own blood. The AutoloGel System is cleared by the United States Food and Drug Administration for use on a variety of exuding wounds. Nuo Therapeutics is headquartered in Gaithersburg, Maryland.
Acquisitions Number:
1
Founded Date:
1987-01-01
Industry:
Biotechnology, Health Care, Manufacturing, Medical, Pharmaceutical, Therapeutics, Wellness
Estimated Revenue:
Less than $1M
Last Funding Type:
Post-IPO Equity
Total Funding:
$112.8M
Headquarters:
Gaithersburg, Maryland, United States
Technology:
Others
Investor Type:
For Profit
Investors Number:
3
Employee Number:
11-50
Funding Status:
IPO